# Cannabis Policy Enforcement and Regulatory Updates > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-policy-enforcement-february-26-2026/ > **Published:** 2026-02-26T01:37:30-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:13:56-04:00 > **Clinical Summary:** Explore cannabis policy enforcement and regulatory updates including federal rescheduling and illegal cannabis operations in this February 26, 2026 review. --- In the Mix** 5 articles reviewed and scored below the CED clinical relevance threshold of 40. Included here for completeness. Some may still be relevant to your situation. #35 CBDPolicyHemp [CBD oil restores quality of life for sisters, sharing concerns about new regulations with hemp …](https://www.wbir.com/article/news/local/knoxville/cbd-oil-restores-quality-of-life-for-sisters/51-192fc109-8067-4115-97e3-15c8945c486a) Two sisters report improved quality of life using 200mg hemp oil full spectrum CBD extract containing THCA, a THC precursor compound. They express concerns about upcoming regulatory changes that could restrict access to THCA-containing hemp products. Patients using full spectrum hemp extracts face potential regulatory restrictions on THCA products despite reported quality of life improvements. [Read more →](https://www.wbir.com/article/news/local/knoxville/cbd-oil-restores-quality-of-life-for-sisters/51-192fc109-8067-4115-97e3-15c8945c486a) #20 PolicySafety [New bill would increase fines, enforcement powers for illegal cannabis** in Nova Scotia](https://www.townandcountrytoday.com/politics/new-bill-would-increase-fines-enforcement-powers-for-illegal-cannabis-in-nova-scotia-11924148) Nova Scotia is introducing legislation to strengthen enforcement against illegal cannabis operations through increased fines and expanded regulatory powers. The bill aims to protect [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) and safety by addressing risks posed by unregulated dispensaries to consumers and youth. Strengthened enforcement mechanisms and penalties for illegal cannabis operations may help protect consumers from unregulated products while supporting the integrity of provincial regulatory frameworks. [Read more →](https://www.townandcountrytoday.com/politics/new-bill-would-increase-fines-enforcement-powers-for-illegal-cannabis-in-nova-scotia-11924148) #15** PolicyIndustry [Is Washington Finally Moving On Federal Cannabis** Rescheduling? – The Dales Report](https://thedalesreport.com/cannabis/is-washington-finally-moving-on-federal-cannabis-rescheduling/) [Federal cannabis rescheduling](https://cedclinic.com/veterans-cannabis-psychedelic-therapy-access-expansion/) efforts in Washington may be gaining traction, with recent market activity suggesting renewed momentum in policy discussions. Industry observers are closely monitoring legislative developments that could significantly impact the legal cannabis market landscape. Recent market movements indicate potential progress on federal cannabis rescheduling, though the timeline and final outcome of policy changes remain uncertain. [Read more →](https://thedalesreport.com/cannabis/is-washington-finally-moving-on-federal-cannabis-rescheduling/) #12** PolicyResearch [The cannabis** debate is heating up in Hawaiʻi and across the U.S. – YouTube](https://www.youtube.com/watch?v=jkde24GHAB4) Cannabis remains legal under Hawaii state law while remaining federally illegal, creating a conflict between state and federal regulations. This legal discrepancy continues to fuel debate across Hawaii and the United States regarding cannabis policy and enforcement. The ongoing conflict between state legalization and federal prohibition of cannabis creates regulatory challenges that complicate clinical access and research opportunities for patients and healthcare providers. [Read more →](https://www.youtube.com/watch?v=jkde24GHAB4) #5 PolicySafety [Autopsy shows 6 gunshot wounds, BAC above legal limit in Dodge’s murder trial – Clarksville Now](https://clarksvillenow.com/local/autopsy-shows-6-gunshot-wounds-bac-above-legal-limit-in-dodges-murder-trial/) A forensic pathologist testified in a murder trial that the victim sustained six gunshot wounds and had detectable levels of alcohol and THC at the time of death. The autopsy findings were presented as evidence during the criminal proceedings. Forensic testimony in a criminal case documented the presence of THC and alcohol in a deceased individual, highlighting how toxicology results are used in legal proceedings. [Read more →](https://clarksvillenow.com/local/autopsy-shows-6-gunshot-wounds-bac-above-legal-limit-in-dodges-murder-trial/) See the top-ranked articles at [cedclinic.com/category/cannabis-news/](https://cedclinic.com/category/cannabis-news/) Digest-Level Clinical Commentary Dr. Caplan’s Take Clinical Reflection The regulatory landscape is shifting toward both stricter enforcement of illicit products and potential federal rescheduling, which could meaningfully expand my ability to prescribe cannabis-derived medications with clearer dosing guidelines and insurance coverage. These concurrent policy movements suggest that [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) practice will increasingly depend on distinguishing between regulated pharmaceutical-grade products and uncontrolled dispensary offerings, making patient education about product standardization and lab testing more clinically essential than ever. The persistent federal-state legal conflicts, particularly evident in Hawaii, will continue to complicate evidence-based prescribing until rescheduling clarifies my prescribing authority and liability protections. Clinical Perspective Clinical Perspective on Cannabis News Themes These items reflect ongoing regulatory fragmentation around cannabis, with jurisdictions independently strengthening enforcement mechanisms (Nova Scotia) and debating rescheduling status (Washington, Hawaii) while clinical evidence lags behind policy changes. The persistence of legal conflicts between state and federal frameworks continues to create clinical complexity, particularly regarding product safety standards and [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/) to evidence-based information. Current discourse remains heavily weighted toward policy and enforcement rather than clinical outcomes or safety data integration into medical practice. PolicySafetyEnforcementFederal RegulationState Law 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+In+the+Mix%3A+5+More+Articles+%E2%80%94+February+26%2C+2026+%40drcaplan&url=) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+In+the+Mix%3A+5+More+Articles+%E2%80%94+February+26%2C+2026+--+via+%40drcaplan.bsky.social+) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [In the Mix: 20 More Articles — March 08, 2026](https://cedclinic.com/cannabis-pediatric-exposure-toxicity-march-08-2026/) - [In the Mix: 5 More Articles — March 07, 2026](https://cedclinic.com) - [In the Mix: 5 More Articles — March 07, 2026](https://cedclinic.com/cannabis-industry-regulatory-challenges-2026/) Further Reading Evidence Watch[Regulatory Digest 2026-03-08](https://cedclinic.com/regulatory-digest-2026-03-09/) Policy Watch[Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I](https://cedclinic.com/dea-temporary-placement-schedule-i-n-desethyl-isotonitazene/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [St. Louis THC shop to shut down over illegal sales – FOX 2](https://cedclinic.com/illegal-cannabis-storefront-enforcement-st-louis/) Learn about enforcement actions against illegal THC sales in St. Louis and their impact on public safety and regulatory compliance. [Read More](https://cedclinic.com/illegal-cannabis-storefront-enforcement-st-louis/) [GOP Lawmakers’ Hemp Amendments To The Farm Bill Would Allow Continued Legal Sales …](https://cedclinic.com/2026-farm-bill-hemp-amendments-legal-thc-sales/) Explore proposed hemp amendments to the Farm Bill aimed at sustaining legal hemp sales and regulatory clarity. [Learn More](https://cedclinic.com/2026-farm-bill-hemp-amendments-legal-thc-sales/) Judge pauses Texas' new ban on smokable THC – San Antonio Express-News Review the recent judicial pause on Texas' smokable THC ban and its implications for cannabis policy enforcement. Discover Details ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).